HLF Insider Trading
HERBALIFE LTD. | Wholesale-Drugs, Proprietaries & Druggists' Sundries
Comprehensive Trading Performance Summary
The investment history of corporate insiders at HERBALIFE LTD. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Wholesale-Drugs, Proprietaries & Druggists' Sundries sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2010-05-15 00:00 | 2010-05-13 | Bermingham Richard P | Director | SELL | $48.97 | 2,775 | $135,892 | 8,905 | -23.8% |
| 2010-05-11 00:23 | 2010-05-06 | HIGBY LAWRENCE M | Director | BUY | $46.27 | 400 | $18,508 | 400 | +100.0% |
| 2010-05-07 02:38 | 2010-05-05 | Barnes Leroy Jr. | Director | OPT+S | $49.03 | 15,625 | $766,094 | 8,804 | 0.0% |
| 2010-05-07 02:36 | 2010-05-04 | Zimmer Thomas | Officer - SVP, North America | OPT+S | $50.00 | 2,250 | $112,500 | 12,202 | 0.0% |
| 2010-05-07 02:34 | 2010-05-04 | LEVY ROBERT | Officer - SVP, WW. Sales & Marketing | SELL | $50.00 | 1,000 | $50,000 | 81,717 | -1.2% |
| 2010-04-02 22:09 | 2010-03-31 | Zimmer Thomas | Officer - SVP, North America | OPT+S | $46.67 | 3,500 | $163,350 | 12,839 | 0.0% |
| 2010-04-02 22:08 | 2010-03-31 | RAHN WILLIAM | Officer - SVP / Mg Dir. - Asia Pacific | OPT+S | $46.08 | 1,000 | $46,080 | 7,623 | 0.0% |
| 2010-03-30 03:12 | 2010-03-29 | RAHN WILLIAM | Officer - SVP / Mg Dir. - Asia Pacific | SELL | $45.00 | 27 | $1,215 | 7,623 | -0.4% |
| 2010-03-27 00:03 | 2010-03-25 | RAHN WILLIAM | Officer - SVP / Mg Dir. - Asia Pacific | SELL | $45.00 | 2,000 | $90,000 | 7,650 | -20.7% |
| 2010-03-10 02:30 | 2010-03-05 | Bermingham Richard P | Director | SELL | $42.92 | 3,124 | $134,092 | 11,680 | -21.1% |
| 2010-03-03 04:01 | 2010-03-01 | JOHNSON MICHAEL | Director, Officer - Chairman & CEO | OPT+S | $40.03 | 96,773 | $3,873,823 | 381,943 | 0.0% |
| 2010-03-03 03:52 | 2010-03-02 | RAHN WILLIAM | Officer - SVP / Mg Dir. - Asia Pacific | OPT+S | $42.15 | 858 | $36,165 | 9,627 | 0.0% |
| 2010-01-21 03:11 | 2010-01-15 | Zimmer Thomas | Officer - SVP, North America | OPT+S | $44.54 | 16,250 | $723,751 | 13,454 | 0.0% |
| 2010-01-05 21:37 | 2009-12-31 | RAHN WILLIAM | Officer - SVP / Mg Dir. - Asia Pacific | OPT+S | $40.55 | 1,000 | $40,550 | 8,055 | 0.0% |
| 2010-01-05 21:36 | 2009-12-31 | Henig Yair Steve | Officer - Chief Scientific Officer | OPT+S | $40.55 | 5,000 | $202,750 | 16,460 | 0.0% |
| 2009-12-22 23:32 | 2009-12-18 | Henig Yair Steve | Officer - Chief Scientific Officer | OPT+S | $41.50 | 7,349 | $304,984 | 16,460 | 0.0% |
| 2009-12-18 04:28 | 2009-12-15 | CHAPMAN BRETT | Officer - General Counsel | OPT+S | $42.00 | 27,683 | $1,162,686 | 44,100 | 0.0% |
| 2009-12-16 02:27 | 2009-12-11 | CHAPMAN BRETT | Officer - General Counsel | OPT+S | $42.00 | 76,900 | $3,229,800 | 43,927 | 0.0% |
| 2009-12-11 02:21 | 2009-12-09 | RAHN WILLIAM | Officer - SVP / Mg Dir. - Asia Pacific | OPT+S | $42.52 | 23,181 | $985,656 | 8,055 | 0.0% |
| 2009-12-02 23:19 | 2009-12-01 | PEZZULLO DAVID | Officer - Chief Accounting Officer | SELL | $43.96 | 6,685 | $293,873 | 29,423 | -18.5% |
| 2009-12-02 23:11 | 2009-11-30 | JOHNSON MICHAEL | Director, Officer - Chairman & CEO | OPT+S | $42.03 | 92,335 | $3,880,840 | 367,175 | 0.0% |
| 2009-11-30 23:55 | 2009-11-25 | Hienrich Edi | Officer - SVP/Managing Director EMEA | OPT+S | $43.52 | 1,800 | $78,336 | 13,045 | 0.0% |
| 2009-11-25 22:17 | 2009-11-23 | Hienrich Edi | Officer - SVP/Managing Director EMEA | OPT+S | $43.50 | 1,800 | $78,300 | 13,045 | 0.0% |
| 2009-11-11 02:42 | 2009-11-09 | CHAPMAN BRETT | Officer - General Counsel | SELL | $40.01 | 20,000 | $800,200 | 43,927 | -31.3% |
| 2009-10-22 01:19 | 2009-10-19 | Henig Yair Steve | Officer - Chief Scientific Officer | OPT+S | $37.73 | 15,000 | $566,000 | 19,388 | 0.0% |
| 2009-10-13 18:36 | 2009-10-08 | Henig Yair Steve | Officer - Chief Scientific Officer | OPT+S | $35.40 | 10,000 | $354,000 | 19,388 | 0.0% |
| 2009-09-23 03:18 | 2009-09-21 | Henig Yair Steve | Officer - Chief Scientific Officer | SELL | $32.78 | 5,300 | $173,734 | 19,388 | -21.5% |
| 2009-08-11 00:25 | 2009-08-10 | Cardoso Pedro | Director | SELL | $32.04 | 1,937 | $62,061 | 0 | -100.0% |
| 2009-03-09 22:38 | 2009-03-09 | Bermingham Richard P | Director | BUY | $12.60 | 3,000 | $37,794 | 14,804 | +25.4% |
| 2009-03-03 04:01 | 2009-03-02 | GOUDIS RICHARD | Officer - Chief Financial Officer | BUY | $13.32 | 75,000 | $999,000 | 125,525 | +148.4% |
| 2008-12-02 00:51 | 2008-11-26 | LEVY ROBERT | Officer - SVP/Worldwide Dist. Sales | BUY | $16.75 | 1,000 | $16,750 | 55,938 | +1.8% |
| 2008-11-24 20:30 | 2008-11-20 | Waisbein Leon | Director | BUY | $15.00 | 50,000 | $750,000 | 369,091 | +15.7% |
| 2008-11-21 03:01 | 2008-11-19 | PEZZULLO DAVID | Officer - Chief Accounting Officer | BUY | $15.69 | 1,585 | $24,869 | 17,974 | +9.7% |
| 2008-11-14 01:21 | 2008-11-12 | Gaba Hal | Director | BUY | $17.70 | 5,000 | $88,500 | 22,484 | +28.6% |
| 2008-11-12 19:44 | 2008-11-11 | CHAPMAN BRETT | Officer - General Counsel | BUY | $18.88 | 100 | $1,888 | 100 | +100.0% |
| 2008-11-07 02:45 | 2008-11-06 | Bermingham Richard P | Director | BUY | $19.55 | 3,000 | $58,650 | 11,804 | +34.1% |
| 2008-11-07 01:08 | 2008-11-06 | Walsh Des | Officer - EVP/Ops. & Sales | BUY | $19.96 | 10,000 | $199,600 | 25,210 | +65.7% |
| 2008-11-06 22:13 | 2008-11-06 | CHAPMAN BRETT | Officer - General Counsel | BUY | $19.31 | 20,000 | $386,200 | 38,386 | +108.8% |
| 2008-11-06 22:09 | 2008-11-06 | PEZZULLO DAVID | Officer - Chief Accounting Officer | BUY | $19.48 | 5,100 | $99,348 | 16,108 | +46.3% |
| 2008-11-06 22:07 | 2008-11-06 | GOUDIS RICHARD | Officer - Chief Financial Officer | BUY | $19.41 | 25,000 | $485,373 | 50,525 | +97.9% |
| 2008-10-02 00:57 | 2008-09-30 | RAHN WILLIAM | Officer - SVP / Mg Dir. ? Asia Pac | OPT+S | $38.75 | 7,750 | $300,313 | 12,395 | 0.0% |
| 2008-08-08 21:21 | 2008-08-06 | Zimmer Thomas | Officer - SVP, North America | OPT+S | $45.00 | 3,250 | $146,250 | 9,518 | 0.0% |
| 2008-08-05 03:50 | 2008-08-01 | Roberts David Wynne | Officer - SVP - EMEA | OPT+S | $43.48 | 52,587 | $2,286,667 | 9,017 | 0.0% |
| 2008-07-12 02:22 | 2008-07-09 | RAHN WILLIAM | Officer - SVP - North Asia | OPT+S | $38.13 | 26,750 | $1,019,961 | 15,372 | 0.0% |
| 2008-04-08 22:28 | 2008-04-04 | PEZZULLO DAVID | Officer - Chief Accounting Officer | OPT+S | $50.35 | 9,500 | $478,316 | 11,301 | 0.0% |
| 2008-04-08 22:25 | 2008-04-04 | LEVY ROBERT | Officer - SVP - South America | OPT+S | $50.16 | 40,000 | $2,006,456 | 54,740 | 0.0% |
| 2008-04-03 04:35 | 2008-03-31 | Zimmer Thomas | Officer - SVP, North America | SELL | $45.54 | 1,450 | $66,033 | 9,396 | -13.4% |
| 2008-04-03 04:28 | 2008-03-31 | Zimmer Thomas | Officer - SVP, North America | OPT+S | $45.96 | 17,550 | $806,623 | 10,846 | 0.0% |
| 2008-04-03 04:27 | 2008-03-31 | NOACK PAUL | Officer - Managing Director - Asia | OPT+S | $45.67 | 3,750 | $171,267 | 42,973 | 0.0% |
| 2008-04-03 04:24 | 2008-03-31 | Bini Eneida | Officer - Senior Vice President, Brazil | OPT+S | $46.34 | 5,250 | $243,300 | 1,437 | 0.0% |
How to Interpret $HLF Trades
Not every insider transaction in HERBALIFE LTD. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HLF shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for HLF
Insider activity data for HERBALIFE LTD. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HLF, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.